11,225 Shares in Astera Labs, Inc. $ALAB Acquired by Integrated Financial Solutions Inc.

Integrated Financial Solutions Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,225 shares of the company’s stock, valued at approximately $2,198,000. Astera Labs accounts for about 1.8% of Integrated Financial Solutions Inc.’s portfolio, making the stock its 11th largest holding.

A number of other institutional investors also recently modified their holdings of ALAB. Assetmark Inc. increased its stake in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Clearstead Trust LLC grew its holdings in shares of Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the last quarter. Advisors Asset Management Inc. increased its position in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after acquiring an additional 194 shares in the last quarter. Manchester Capital Management LLC raised its holdings in shares of Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after acquiring an additional 283 shares during the last quarter. Finally, Whittier Trust Co. acquired a new stake in shares of Astera Labs in the 3rd quarter worth about $55,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on ALAB shares. BNP Paribas Exane began coverage on Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating for the company. TD Cowen restated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Roth Mkm upped their price target on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Raymond James Financial started coverage on Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating for the company. Finally, Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. Fourteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $192.89.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 4,849 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total value of $600,306.20. Following the transaction, the general counsel directly owned 138,084 shares in the company, valued at approximately $17,094,799.20. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the company’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 389,792 shares of company stock worth $56,013,809 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs Stock Performance

Shares of ALAB stock opened at $118.83 on Friday. The company has a market capitalization of $20.23 billion, a PE ratio of 97.40, a price-to-earnings-growth ratio of 2.45 and a beta of 1.50. The business’s fifty day moving average is $158.18 and its 200 day moving average is $172.60. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period last year, the firm posted $0.37 EPS. Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.